247 filings
8-K
ABEO
Abeona Therapeutics Inc
3 May 24
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
5:16pm
8-K
ABEO
Abeona Therapeutics Inc
3 May 24
Results of Operations and Financial Condition
6:45am
8-K
ABEO
Abeona Therapeutics Inc
24 Apr 24
Departure of Directors or Certain Officers
4:05pm
8-K
ABEO
Abeona Therapeutics Inc
22 Apr 24
Abeona Therapeutics Provides Regulatory Update on Pz-cel
4:05pm
8-K
ABEO
Abeona Therapeutics Inc
18 Mar 24
Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
8:36am
8-K
wkxl44i58o
8 Jan 24
Abeona Therapeutics Announces $50 Million Credit Facility
7:35am
8-K
s7vl dtafxa236
27 Nov 23
Other Events
7:30am
8-K
f5cet d8fc
13 Nov 23
Abeona Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Developments
7:35am
8-K
3utr hpt6p
18 Oct 23
Changes in Registrant's Certifying Accountant
7:30am
8-K
nbbwc5lde6o552bz7
8 Aug 23
Abeona Therapeutics Reports Second Quarter 2023 Financial Results
8:30am
8-K
2mic cbg7sgt13mwv
7 Jul 23
Abeona Therapeutics Announces Closing of $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
8:41am
8-K
bcxif19
3 Jul 23
Abeona Therapeutics Announces $25 Million Registered Direct Offering
8:54am
8-K
jrwiq5l6q2fjr 4aarn5
17 May 23
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
ttakizifsxlth
11 May 23
Abeona Therapeutics Reports First Quarter 2023 Financial Results
7:30am
8-K
pq45d116074ei6 ev
11 Apr 23
Departure of Directors or Certain Officers
4:30pm
8-K
361ed
29 Mar 23
Abeona Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update
7:35am
8-K
oft18
13 Mar 23
Regulation FD Disclosure
7:00am
8-K
zaf0ojl
14 Nov 22
Abeona Therapeutics Reports Third Quarter 2022 Financial Results
7:35am
8-K
yfz96ah8diq9
3 Nov 22
Abeona Therapeutics Announces $35 Million Private Placement Financing
5:20pm
8-K
0i52wsd
3 Nov 22
Regulation FD Disclosure
7:32am